Skip to main content

Table 1 Patient demographics

From: Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1)

Characteristic Number of patients (%), N = 18
Gender
Male 12 (67)
Female 6 (33)
Age (years)   
Median 60  
Range 49 -74  
ECOG performance
Grade 0 16 (89)
Grade 1 2 (11)
Body mass index (kg/m2)
Median 21  
Range 20 - 24  
Primary site   
Cavity of the mouth 8 (44)
Oropharynx 10 (56)
Tumor volume (ml) of primary tumor
Median 25  
Range 3 - 84  
AJCC stage
III 2 (11)
IVA 16 (89)
HPV status   
Negative 15 (83)
Positive 3 (17)
  1. ECOG, Eastern Cooperative Oncology Group; AJCC, American Joint Committee on Cancer; HPV, Human papilloma virus.